Clinical Trials Browser

NCT06463587 2026-03-19

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Phase 3 Recruiting

264 enrolled

Myasthenia Gravis

NCT07463521 2026-03-17

MyVision

Phase 3 Not yet recruiting

120 enrolled

Myasthenia Gravis

NCT07478172 2026-03-17

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Phase NA Recruiting

50 enrolled

Amyotrophic Lateral Sclerosis, Charcot-Marie-Tooth Disease, Glycogen Storage Disease Type II, Muscular Atrophy, Spinal, Myasthenia Gravis, Neuromuscular Diseases, Spastic Paraplegia, Hereditary, Lambert-Eaton Myasthenic Syndrome, Postpoliomyelitis Syndrome, Motor Neuron Disease, Mitochondrial Myopathies, Myopathies, Nemaline, Myositis, Inclusion Body, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Muscular Dystrophy, Facioscapulohumeral, Myopathies, Structural, Congenital, Postural Orthostatic Tachycardia Syndrome

NCT06607627 2026-03-16

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

Phase 3 Recruiting

12 enrolled

Myasthenia Gravis

NCT06700616 2026-03-16

MG Cohort

Active not recruiting

1,199 enrolled

Myasthenia Gravis

NCT06987539 2026-03-16

THYME

Phase 2 Recruiting

15 enrolled

Myasthenia Gravis

NCT07472777 2026-03-16

Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis

Completed

231 enrolled

Myasthenia Gravis, Recurrence

NCT05265273 2026-03-13

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

Phase 2/3 Recruiting

12 enrolled

Myasthenia Gravis

NCT06435312 2026-03-13

ziMyG+

Phase 3 Enrolling by invitation

8 enrolled

Myasthenia Gravis

NCT06909253 2026-03-13

MG-ARCADIA

Recruiting

50 enrolled

Myasthenia Gravis

NCT07217587 2026-03-13

EPIC

Phase 3 Recruiting

115 enrolled

Myasthenia Gravis

NCT07246564 2026-03-13

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis

Phase 4 Recruiting

40 enrolled

Myasthenia Gravis

NCT07247279 2026-03-13

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

Recruiting

450 enrolled

Myasthenia Gravis, Rare Diseases

NCT07470151 2026-03-13

Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

Phase NA Recruiting

12 enrolled

Autoimmune Diseases, Lupus Erythematosus, Systemic, Myasthenia Gravis, Scleroderma, Diffuse

NCT07465289 2026-03-11

A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

Phase 3 Not yet recruiting

100 enrolled

Myasthenia Gravis

NCT04524273 2026-03-10

MINT

Phase 3 Active not recruiting

238 enrolled 36 charts

Myasthenia Gravis

NCT06414954 2026-03-10

SYNAPSE-MG

Phase 2 Recruiting

84 enrolled

Myasthenia Gravis

NCT06456580 2026-03-10

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Phase 3 Recruiting

180 enrolled

Myasthenia Gravis

NCT07304154 2026-03-10

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

Phase 1 Not yet recruiting

52 enrolled

Multiple Sclerosis, Myasthenia Gravis, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT05403541 2026-03-06

Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis

Phase 3 Active not recruiting

240 enrolled

Myasthenia Gravis

NCT07039916 2026-03-06

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Phase 3 Recruiting

231 enrolled

Autoimmune Diseases, Myasthenia Gravis

NCT07298928 2026-03-06

A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis

Phase NA Not yet recruiting

30 enrolled

Myasthenia Gravis

NCT04951622 2026-03-03

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Phase 3 Recruiting

199 enrolled 11 charts

Myasthenia Gravis

NCT07221838 2026-03-03

OCTAGON

Phase 4 Not yet recruiting

75 enrolled

Adrenal Insufficiency, Myasthenia Gravis

NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Phase 2 Active not recruiting

53 enrolled

CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

NCT06055959 2026-02-27